National Health Surveillance Agency – ANVISA
April 15, 2021
The authorization of two new Cannabis products was published by The National Health Surveillance Agency (ANVISA) on Thursday, April 15th. The approved products are oral solutions containing up to 0.2% THC and must be prescribed by a type B prescription. This authorization allows for the import of the products ready for use, along with marketing the products within Brazil.
Read the full article here.
